+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Competent Cells - Market Analysis, Trends, and Forecasts

  • ID: 4804215
  • Report
  • February 2020
  • Region: Global
  • 134 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • MORE
Competent Cells market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 9.8%. Chemically Competent Cells, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2 Billion by the year 2025, Chemically Competent Cells will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$63.3 Million to the region's size and clout in the next 5 to 6 years. Over US$64.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Chemically Competent Cells will reach a market size of US$146.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.4% over the next couple of years and add approximately US$238.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Merck KgaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

Clean-Label Starch Innovations

Chemically Competent Cells Segment Dominate in North America

Drivers & Restrains Summarized for Competent Cells Market

Cloning is Expected to Take the Largest Share of Competent Cells Market

Competent Cells Growth Outlook

Competent Cells Application Trends

Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market

Leading Players in competent cells market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Advancements in Molecular Cloning Drives Competent Cell Market

Drivers and Restraints Summarised

SGI-DNA Inc has Launched Vmax™ Express Chemically Competent Cells .

Increasing Research on Cloning Demands Competent Cells Requirement

Increasing Intensity of Research and Technological Advancements Drives Market

Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells

Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022

As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells

Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins

Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells

Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells

Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth

Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods

Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method

Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells

Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024

Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth

Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery

Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030

Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Competent Cells Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Competent Cells Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

TABLE 3: Chemically Competent Cells (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 4: Chemically Competent Cells (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

TABLE 5: Electrocompetent Cells (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 6: Electrocompetent Cells (Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025

TABLE 7: Cloning (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 8: Cloning (Application) Market Share Breakdown by Region/Country: 2019 VS 2025

TABLE 9: Protein Expression (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025

TABLE 10: Protein Expression (Application) Share Breakdown Review by Region/Country: 2019 VS 2025

TABLE 11: Other Applications (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 12: Other Applications (Application) Distribution of Global Sales by Region/Country: 2019 VS 2025

TABLE 13: Pharmaceutical & Biotechnology Companies (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025

TABLE 14: Pharmaceutical & Biotechnology Companies (End-Use) Global Market Share Distribution by Region/Country for 2019 and 2025

TABLE 15: Academic Research Institutes (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025

TABLE 16: Academic Research Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025

TABLE 17: Contract Research Organizations (CROs) (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025

TABLE 18: Contract Research Organizations (CROs) (End-Use) Market Share Shift across Key Geographies: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Competent Cells Market Share (in %) by Company: 2019 & 2025

Market Analytics

TABLE 19: United States Competent Cells Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 20: United States Competent Cells Market Share Breakdown by Type: 2019 VS 2025

TABLE 21: United States Competent Cells Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025

TABLE 22: Competent Cells Market Share Breakdown in the United States by Application: 2019 VS 2025

TABLE 23: United States Competent Cells Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025

TABLE 24: Competent Cells Market Share Breakdown in the United States by End-Use: 2019 VS 2025

CANADA

TABLE 25: Canadian Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 26: Competent Cells Market in Canada: Percentage Share Breakdown of Sales by Type for 2019 and 2025

TABLE 27: Canadian Competent Cells Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025

TABLE 28: Canadian Competent Cells Market Share Analysis by Application: 2019 VS 2025

TABLE 29: Canadian Competent Cells Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 30: Canadian Competent Cells Market Share Analysis by End-Use: 2019 VS 2025

JAPAN

TABLE 31: Japanese Market for Competent Cells: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 32: Japanese Competent Cells Market Share Analysis by Type: 2019 VS 2025

TABLE 33: Japanese Demand Estimates and Forecasts for Competent Cells in US$ Thousand by Application: 2018 to 2025

TABLE 34: Competent Cells Market Share Shift in Japan by Application: 2019 VS 2025

TABLE 35: Japanese Demand Estimates and Forecasts for Competent Cells in US$ Thousand by End-Use: 2018 to 2025

TABLE 36: Competent Cells Market Share Shift in Japan by End-Use: 2019 VS 2025

CHINA

TABLE 37: Chinese Competent Cells Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 38: Chinese Competent Cells Market by Type: Percentage Breakdown of Sales for 2019 and 2025

TABLE 39: Chinese Demand for Competent Cells in US$ Thousand by Application: 2018 to 2025

TABLE 40: Chinese Competent Cells Market Share Breakdown by Application: 2019 VS 2025

TABLE 41: Chinese Demand for Competent Cells in US$ Thousand by End-Use: 2018 to 2025

TABLE 42: Chinese Competent Cells Market Share Breakdown by End-Use: 2019 VS 2025

EUROPE

Market Facts & Figures

European Competent Cells Market: Competitor Market Share Scenario (in %) for 2019 & 2025

Market Analytics

TABLE 43: European Competent Cells Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 44: European Competent Cells Market Share Shift by Region/Country: 2019 VS 2025

TABLE 45: European Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 46: European Competent Cells Market Share Breakdown by Type: 2019 VS 2025

TABLE 47: European Competent Cells Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 48: European Competent Cells Market Share Analysis by Application: 2019 VS 2025

TABLE 49: European Competent Cells Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 50: European Competent Cells Market Share Analysis by End-Use: 2019 VS 2025

FRANCE

TABLE 51: Competent Cells Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 52: French Competent Cells Market Share Analysis by Type: 2019 VS 2025

TABLE 53: Competent Cells Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025

TABLE 54: French Competent Cells Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

TABLE 55: Competent Cells Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025

TABLE 56: French Competent Cells Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025

GERMANY

TABLE 57: Competent Cells Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 58: German Competent Cells Market Share Breakdown by Type: 2019 VS 2025

TABLE 59: Competent Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025

TABLE 60: Competent Cells Market Share Distribution in Germany by Application: 2019 VS 2025

TABLE 61: Competent Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025

TABLE 62: Competent Cells Market Share Distribution in Germany by End-Use: 2019 VS 2025

ITALY

TABLE 63: Italian Competent Cells Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 64: Italian Competent Cells Market by Type: Percentage Breakdown of Sales for 2019 and 2025

TABLE 65: Italian Demand for Competent Cells in US$ Thousand by Application: 2018 to 2025

TABLE 66: Italian Competent Cells Market Share Breakdown by Application: 2019 VS 2025

TABLE 67: Italian Demand for Competent Cells in US$ Thousand by End-Use: 2018 to 2025

TABLE 68: Italian Competent Cells Market Share Breakdown by End-Use: 2019 VS 2025

UNITED KINGDOM

TABLE 69: United Kingdom Market for Competent Cells: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 70: United Kingdom Competent Cells Market Share Analysis by Type: 2019 VS 2025

TABLE 71: United Kingdom Demand Estimates and Forecasts for Competent Cells in US$ Thousand by Application: 2018 to 2025

TABLE 72: Competent Cells Market Share Shift in the United Kingdom by Application: 2019 VS 2025

TABLE 73: United Kingdom Demand Estimates and Forecasts for Competent Cells in US$ Thousand by End-Use: 2018 to 2025

TABLE 74: Competent Cells Market Share Shift in the United Kingdom by End-Use: 2019 VS 2025

REST OF EUROPE

TABLE 75: Rest of Europe Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 76: Rest of Europe Competent Cells Market Share Breakdown by Type: 2019 VS 2025

TABLE 77: Rest of Europe Competent Cells Addressable Market Opportunity in US$ Thousand by Application: 2018-2025

TABLE 78: Rest of Europe Competent Cells Market Share Analysis by Application: 2019 VS 2025

TABLE 79: Rest of Europe Competent Cells Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025

TABLE 80: Rest of Europe Competent Cells Market Share Analysis by End-Use: 2019 VS 2025

ASIA-PACIFIC

TABLE 81: Competent Cells Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 82: Asia-Pacific Competent Cells Market Share Analysis by Type: 2019 VS 2025

TABLE 83: Competent Cells Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025

TABLE 84: Asia-Pacific Competent Cells Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

TABLE 85: Competent Cells Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025

TABLE 86: Asia-Pacific Competent Cells Market Share Analysis: A 7-Year Perspective by End-Use for 2019 and 2025

REST OF WORLD

TABLE 87: Rest of World Competent Cells Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 88: Competent Cells Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2019 and 2025

TABLE 89: Rest of World Competent Cells Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025

TABLE 90: Rest of World Competent Cells Market Share Analysis by Application: 2019 VS 2025

TABLE 91: Rest of World Competent Cells Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2018 to 2025

TABLE 92: Rest of World Competent Cells Market Share Analysis by End-Use: 2019 VS 2025

IV. COMPETITION

AGILENT TECHNOLOGIES

BIO-RAD LABORATORIES

GENSCRIPT BIOTECH CORPORATION

ILLUMINA

MERCK KGAA

NEW ENGLAND BIOLABS

ORIGENE TECHNOLOGIES

PROMEGA CORPORATION

QIAGEN NV

TAKARA BIO

THERMO FISHER SCIENTIFIC

ZYMO RESEARCH CORPORATION

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • GENSCRIPT BIOTECH CORPORATION
  • ILLUMINA
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • PROMEGA CORPORATION
  • QIAGEN NV
  • TAKARA BIO
  • THERMO FISHER SCIENTIFIC
  • ZYMO RESEARCH CORPOR
Note: Product cover images may vary from those shown
Adroll
adroll